Although alpha-synuclein is highly expressed in neuronal synapses, the functional role of this protein remains unclear. Elucidating the physiological function of alpha-synuclein is important as this protein is implicated as a causative factor in familial Parkinson disease (PD), primarily because of its association with Lewy bodies, a pathological marker of PD. In cell lines transfected with either mutant alpha- synuclein or wildtype alpha-synuclein, wildtype but not mutant alpha- synuclein associate with lipid droplets, suggesting that the native protein may be involved in lipid trafficking or metabolism. In a parallel set of studies using alpha-synuclein gene-abated mice, there was a large decrease in the steady-state mass of a number of different phospholipids in both whole brain and isolated synaptosomes compared to control mice. Further, there was a significant decrease in the amount of docosahexaenoic acid in a number of different phospholipid classes, suggesting a decrease in uptake and trafficking of docosahexaenoic acid. These data suggest a down-regulation of neuronal lipid metabolism. Because fatty acid binding proteins can alter phospholipid metabolism and alter phospholipid acyl chain composition, I submit the following hypothesis: alpha-Synuclein directly affects fatty acid uptake and targeting in neurons, essentially functioning as a neuronal fatty acid binding protein. However, this hypothesis that alpha-synuclein has a role in neuronal lipid uptake, trafficking, and metabolism needs to be further elucidated using a combination of whole animal and cell culture studies. The following specific aims are designed to address the potential role of alpha-synuclein in brain lipid metabolism using alpha- synuclein gene abated mice, neuronal cultures derived from these mice, and stably transfected H293 cells expressing mutant and wildtype alpha-synuclein.
These aims are: 1. Determine the effect of alpha-synuclein on the uptake and subsequent metabolism of [3H]-palmitic, [3H]-arachidonic, and [3H]- docosahexaenoic acid in brains of control and alpha-synuclein gene- abated mice in vivo using steady-state tracer kinetic analysis. 2. Using cells derived from control and gene-abated mice as well as stably transfected cell lines, determine the effect of alpha-synuclein on cellular fatty acid uptake, metabolism, and trafficking.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21NS043697-02
Application #
6640254
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Program Officer
Murphy, Diane
Project Start
2002-06-01
Project End
2005-05-31
Budget Start
2003-06-01
Budget End
2005-05-31
Support Year
2
Fiscal Year
2003
Total Cost
$167,794
Indirect Cost
Name
University of North Dakota
Department
Pharmacology
Type
Schools of Medicine
DUNS #
102280781
City
Grand Forks
State
ND
Country
United States
Zip Code
58202
Golovko, Mikhail Y; Barceló-Coblijn, Gwendolyn; Castagnet, Paula I et al. (2009) The role of alpha-synuclein in brain lipid metabolism: a downstream impact on brain inflammatory response. Mol Cell Biochem 326:55-66
Golovko, Mikhail Y; Rosenberger, Thad A; Feddersen, Soren et al. (2007) Alpha-synuclein gene ablation increases docosahexaenoic acid incorporation and turnover in brain phospholipids. J Neurochem 101:201-11
Golovko, Mikhail Y; Rosenberger, Thad A; Faergeman, Nils J et al. (2006) Acyl-CoA synthetase activity links wild-type but not mutant alpha-synuclein to brain arachidonate metabolism. Biochemistry 45:6956-66
Austin, Susan A; Floden, Angela M; Murphy, Eric J et al. (2006) Alpha-synuclein expression modulates microglial activation phenotype. J Neurosci 26:10558-63
Castagnet, P I; Golovko, M Y; Barcelo-Coblijn, G C et al. (2005) Fatty acid incorporation is decreased in astrocytes cultured from alpha-synuclein gene-ablated mice. J Neurochem 94:839-49
Murphy, Eric J; Owada, Yuji; Kitanaka, Noriko et al. (2005) Brain arachidonic acid incorporation is decreased in heart fatty acid binding protein gene-ablated mice. Biochemistry 44:6350-60
Ellis, Christopher E; Murphy, Eric J; Mitchell, Drake C et al. (2005) Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking alpha-synuclein. Mol Cell Biol 25:10190-201
Golovko, Mikhail Y; Faergeman, Nils J; Cole, Nelson B et al. (2005) Alpha-synuclein gene deletion decreases brain palmitate uptake and alters the palmitate metabolism in the absence of alpha-synuclein palmitate binding. Biochemistry 44:8251-9
Golovko, Mikhail Y; Murphy, Eric J (2004) An improved method for tissue long-chain acyl-CoA extraction and analysis. J Lipid Res 45:1777-82